|
|
Transcripts that showed significantly decreased expression in N2 day 7 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day7_vs_Day1_downregulated_Illumina
|
|
|
Transcripts that showed significantly decreased expression in N2 day 10 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day10_vs_Day1_downregulated_Illumina
|
|
|
Transcripts that showed significantly decreased expression in N2 day 15 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day15_vs_Day1_downregulated_Illumina
|
|
|
Transcripts that showed significantly increased expression in daf-2(e1370) comparing to in N2. |
Student's t-test, fold change > 2, p-value < 0.05. |
WBPaper00055386:daf-2(e1370)_upregulated
|
|
|
Transcripts that interact with 3xFLAG-DLC-1 as identified by immunoprecipitation followed by RNA sequencing. |
DESeq2, fold change > 2,, p-value < 0.01 |
WBPaper00055334:DLC-1_interacting
|
|
|
Transcripts activated by glp-1(ar202), a gain-of-function allele of glp-1, in the gld-2(q497) gld-1(q485) background at young adult stage, comparing to glp-1(q175) null allele. |
edgeR fold change >= 2, FDR <= 0.05. |
WBPaper00059440:GLP-1_activated
|
|
|
Transcripts activated by lag-1(oz536oz537), in the gld-2(q497)gld-1(q485); glp-1(ar202) background at young adult stage after 48 hours of 1mM auxin treatment. |
edgeR fold change >= 2, FDR <= 0.05. |
WBPaper00059440:LAG-1_activated_48hr-auxin
|